AZD0095
CAS No. 2750001-23-9
AZD0095( —— )
Catalog No. M35816 CAS No. 2750001-23-9
AZD0095 is a selective inhibitor of MCT4 with an IC50 of 1.3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 282 | In Stock |
|
| 5MG | 217 | In Stock |
|
| 10MG | 353 | In Stock |
|
| 25MG | 549 | In Stock |
|
| 50MG | 775 | In Stock |
|
| 100MG | 1070 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZD0095
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD0095 is a selective inhibitor of MCT4 with an IC50 of 1.3 nM.
-
DescriptionAZD0095 is a selective and orally active MCT4 inhibitor (IC50: 1.3 nM). AZD0095 effectively inhibits the tumor growth in NCI-H358 xenograft in combination with Cediranib (HY-10205).
-
In Vitro——
-
In VivoAnimal Model:Murine NCI-H358 xenograft Dosage:100 mg/kg together with Cediranib (3 mg/kg) Administration:Oral administration (p.o.)Result:Reduced tumor growth more efficiently than AZD0095 or AZD2171 alone.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonocarboxylate Transporter
-
RecptorMonocarboxylate transporter
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2750001-23-9
-
Formula Weight500.6
-
Molecular FormulaC27H32N8O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (19.98 mM; Ultrasonic )
-
SMILESCc1nc2nc(C)c(O[C@@H]3CCN(C3)c3ccc(cc3)-c3ccc(CN4CCOCC4)nn3)c(C)n2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goldberg FW, et al. Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. J Med Chem. 2022 Dec 16. ?
molnova catalog
related products
-
BAR 501
BAR501 is an effective and specific GPBAR1 agonist (EC50: 1 μM).
-
7ACC2
7ACC2 is a new potent MCT inhibitor with IC50 of 11 nM for inhibition of [14C]-lactate influx; new antitumor treatment targeting lactate transport in Y cells.
-
7-(Diethylamino)coum...
7-(Diethylamino)coumarin-3-carboxylic acid(7ACC) selectively affects a single part of the MCT symporter translocation cycle leading to strict inhibition of lactate influx. This singular activity is associated with antitumor effects less prone to resistance and side effects.
Cart
sales@molnova.com